Cargando…
Health and cost impact of stepping down asthma medication for UK patients, 2001–2017: A population-based observational study
BACKGROUND: Guidelines recommend stepping down asthma treatment to the minimum effective dose to achieve symptom control, prevent adverse side effects, and reduce costs. Limited data exist on asthma prescription patterns in a real-world setting. We aimed to evaluate the appropriateness of doses pres...
Autores principales: | Bloom, Chloe I., de Preux, Laure, Sheikh, Aziz, Quint, Jennifer K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373267/ https://www.ncbi.nlm.nih.gov/pubmed/32692744 http://dx.doi.org/10.1371/journal.pmed.1003145 |
Ejemplares similares
-
Qualitative Study of Practices and Challenges of Stepping Down Asthma Medication in Primary Care Across the UK
por: Bloom, Chloe I, et al.
Publicado: (2020) -
Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study
por: Attar-Zadeh, Darush, et al.
Publicado: (2023) -
Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017
por: Salciccioli, Justin D., et al.
Publicado: (2022) -
Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)
por: Nissen, Francis, et al.
Publicado: (2019) -
Nontuberculous mycobacterial disease managed within UK primary care, 2006–2016
por: Axson, Eleanor L., et al.
Publicado: (2018)